Yun Wang

Yun Wang has a diverse work experience in the field of translational research and immuno-oncology. They are currently serving as the Director of Translational Research at TScan Therapeutics starting in May 2022. Prior to this, they worked at Valo as a Principal Scientist in Translational Science from April 2021 to May 2022. From August 2016 to April 2021, Yun Wang held the position of Senior Scientist in Immuno-oncology at Merck. They also worked at Invivotek, LLC as a Scientist in Immuno-oncology from August 2015 to August 2016, where they conducted pre-clinical studies and developed in vivo and in vitro models for immunotherapy antibodies. Yun Wang's earlier experience includes working as a Postdoctoral Fellow at the University of California San Diego from January 2013 to August 2015, where they conducted research on inflammatory responses and mitochondrial function in various disease models.

Yun Wang obtained a PhD in Inflammation and Immunology from Purdue University between 2007 and 2012.